Trends of therapy in the treatment of asthma

被引:17
作者
Lv, Xiaodi [1 ,2 ]
Gao, Zhen [1 ,2 ]
Tang, Weifeng [1 ,2 ]
Qin, Jingjing [1 ,2 ]
Wang, Wenqian [1 ,2 ]
Liu, Jiaqi [1 ,2 ]
Li, Mihui [1 ,2 ]
Teng, Fangzhou [1 ,2 ]
Yi, La [1 ,2 ]
Dong, Jingcheng [1 ,2 ]
Wei, Ying [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Integrat Med, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China
[2] Fudan Univ, Inst Integrat Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
asthma; bibliometric analysis; future trends; mechanisms; therapy; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; CELL-DEATH; MEPOLIZUMAB; EFFICACY; SAFETY; ADULTS; BENRALIZUMAB; ANTAGONIST;
D O I
10.1177/17534666231155748
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background:To better understand the development of therapy for asthma, grasp the core paradigm associated with the transformation of cognition of asthma treatment and asthma, explore potential and effective therapies for asthma, discover new biomarkers and mechanisms related to asthma treatment, find novel targets for anti-asthma drugs, and predict the future trends of asthma therapy, we used a bibliometric analysis to research articles related to the therapies for asthma published from 1983 to 2022. Methods:A comprehensive search was conducted to analyze the articles associated with therapy for asthma with the help of the Web of Science Core Collection (WOSCC) database from January 1, 1983 to August 14, 2022. The CiteSpace 6.1.R2 software and VOS viewer 6.1.8 software were utilized to analyze the overall structure of the network, network clusters, links between clusters, key nodes, and pathways. Results:A total of 3902 publications related to therapies on asthma were published in 3211 academic journals by a total of 14,655 authors in 3476 organizations from 87 countries or regions from 1983 to 2022. The United States published the most articles (n = 1143), followed by England (n = 574) and China (n = 405). However, the centrality of China was 0.4, higher than the United States (centrality = 0.16) and Singapore (centrality = 0.11). Akdis Cezmi published the most papers. Journal of Allergy and Clinical Immunology published the most studies on therapies for asthma. Asthma was the most frequent keyword (n = 594). The betweenness centrality value of keywords that were greater than 0.1 included airway inflammation (centrality = 0.22), double blind (centrality = 0.18), asthma (centrality = 0.17), inflammation (centrality = 0.12), and inhaled corticosteroid (centrality = 0.11). Conclusions:The results from this biometric review provide insight into the development of therapy for asthma, the paradigm of recognition of this field, the approach of discovering new targets, exploration and combination of new mechanisms, and the frontier trend of this field in future.
引用
收藏
页数:22
相关论文
共 59 条
[1]   Underdiagnosis and Overdiagnosis of Asthma [J].
Aaron, Shawn D. ;
Boulet, Louis Philippe ;
Reddel, Helen K. ;
Gershon, Andrea S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) :1012-1020
[2]   Lysosomal cell death at a glance [J].
Aits, Sonja ;
Jaattela, Marja .
JOURNAL OF CELL SCIENCE, 2013, 126 (09) :1905-1912
[3]   Trends in worldwide asthma prevalence [J].
Asher, M. Innes ;
Garcia-Marcos, Luis ;
Pearce, Neil E. ;
Strachan, David P. .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (06)
[4]   A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma [J].
Barnes, N. ;
Pavord, I. ;
Chuchalin, A. ;
Bell, J. ;
Hunter, M. ;
Lewis, T. ;
Parker, D. ;
Payton, M. ;
Collins, L. Pearce ;
Pettipher, R. ;
Steiner, J. ;
Perkins, C. M. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (01) :38-48
[5]   Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma [J].
Bel, Elisabeth H. ;
Wenzel, Sally E. ;
Thompson, Philip J. ;
Prazma, Charlene M. ;
Keene, Oliver N. ;
Yancey, Steven W. ;
Ortega, Hector G. ;
Pavord, Ian D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) :1189-1197
[6]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[7]   Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial [J].
Bleecker, Eugene R. ;
FitzGerald, J. Mark ;
Chanez, Pascal ;
Papi, Alberto ;
Weinstein, Steven F. ;
Barker, Peter ;
Sproule, Stephanie ;
Gilmartin, Geoffrey ;
Aurivillius, Magnus ;
Werkstrom, Viktoria ;
Goldman, Mitchell .
LANCET, 2016, 388 (10056) :2115-2127
[8]   Rete-netzwerk-red: analyzing and visualizing scholarly networks using the Network Workbench Tool [J].
Boerner, Katy ;
Huang, Weixia ;
Linnemeier, Micah ;
Duhon, Russell J. ;
Phillips, Patrick ;
Ma, Nianli ;
Zoss, Angela M. ;
Guo, Hanning ;
Price, Mark A. .
SCIENTOMETRICS, 2010, 83 (03) :863-876
[9]   Neutrophil extracellular traps kill bacteria [J].
Brinkmann, V ;
Reichard, U ;
Goosmann, C ;
Fauler, B ;
Uhlemann, Y ;
Weiss, DS ;
Weinrauch, Y ;
Zychlinsky, A .
SCIENCE, 2004, 303 (5663) :1532-1535
[10]   Advances in immunology - Asthma [J].
Busse, WW ;
Lemanske, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :350-362